This inventor holds 15 USPTO granted patents, primarily in Radiopharmaceuticals. Top assignees: The Dow Chemical Company, Dow Global Technolgoies LLC. Active years: 1989-2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1989-2006
Areas of Expertise:
Title: Innovations and Contributions of Kenneth McMillan
Introduction
Kenneth McMillan is a notable inventor based in Richwood, Texas, with a remarkable portfolio of 15 patents. His work primarily focuses on the medical applications of radiopharmaceuticals, showcasing his commitment to advancing healthcare technologies.
Latest Patents
Among his latest patents, one significant invention is the treatment of osteomyelitis with radiopharmaceuticals. This invention relates to the medical uses of radiopharmaceuticals, specifically targeting the treatment of osteomyelitis. The present invention provides improved systems and methods for the direct delivery of radiopharmaceuticals to the site of osteomyelitis. Another notable patent is for frozen radiopharmaceutical formulations. This invention involves formulations for complexes comprising at least one radionuclide complexed with a ligand, particularly .sup.153 samarium-ethylenediaminetetramethylenephosphonic acid. This formulation can optionally contain a divalent metal ion, such as calcium, and is designed to be frozen, thawed, and then administered by injection.
Career Highlights
Throughout his career, Kenneth has made significant contributions to the field of radiopharmaceuticals. He has worked with prominent companies, including The Dow Chemical Company and Dow Global Technologies LLC. His experience in these organizations has allowed him to develop innovative solutions that address critical medical challenges.
Collaborations
Kenneth has collaborated with several professionals in his field, including Jaime Simon and David A Wilson. These collaborations have further enriched his work and contributed to the success of his inventions.
Conclusion
Kenneth McMillan's innovative work in the field of radiopharmaceuticals has made a significant impact on medical treatments, particularly for osteomyelitis. His dedication to advancing healthcare through his inventions is commendable and highlights the importance of innovation in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile